|Articles|July 19, 2002
CDER's Experience: What We Have Learned from The Pediatric Initiative
19 JULY -
Advertisement
CDER's Experience: What We Have Learned from The Pediatric Initiative --William Rodriguez, M.D.http://www.fda.gov/cder/pediatric/presentation/ped_init_rodriguez/index.htm
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Charles River Incubator Cohort to Accelerate CGT Development
2
GSK and Oxford BioTherapeutics Drive Antibody-Based Cancer Drug Discovery at Industry Scale
3
FDA Decision Accelerates Rare Disease Gene Therapy Regulatory Pathways
4
BioPharma By The Numbers: Batch Failures in Biopharma Manufacturing
5
